Eating more whole fruits, particularly blueberries, grapes, and apples, was significantly associated with a lower risk of type 2 diabetes, according to a new study led by Harvard School of Public Health (HSPH) researchers.
Previous studies have shown that oxidative stress levels can increase during acute or chronic blood glucose fluctuation in body in type 2 diabetes (T2DM) patients. Elevation in oxidative stress level can damage cell and tissue. Therefore, it is essential to assess the relationship between coronary artery complications and fluctuation in glucose level.
Can consuming dairy products reduce your risk of developing type 2 diabetes? The answer, according to a systematic review published in the American Journal of Clinical Nutrition last week, is a qualified YES.
Glucagon, a hormone involved in regulating appetite, loses its ability to help obese people feel full after a meal, but it continues to suppress hunger pangs in people with type 1 diabetes, according to a recent study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM).
The score, based on age, education, heart disease, metabolic events, and other factors, was a significant predictor of dementia risk over a 10-year period (C-statistic 0.736), Rachel Whitmer, PhD, of Kaiser Permanente in Oakland, Calif., and colleagues reported online in The Lancet Diabetes and Endocrinology.
Something really interesting came out of just such a project from the lab of Dr. Mike Snyder at Stanford University. Over the course of the experiment, Mike developed type 2 diabetes. And not only did we get to pretty much watch this happen in real time, but we also got to see that it might […]
If you’ve been diagnosed with Type 2 diabetes within the past five years, then you may be eligible to help researchers test treatments in a study sponsored by the National Institutes of Health (NIH).
Approximately 25% of strokes experienced by type 2 diabetic patients are of unknown cause, however, a recent study is finding subclinical Afib as a possible “common etiologic factor.” In the cohort designed study, 462 type 2 diabetic patients under the age of 60 were matched to “healthy controls” (patients without diabetes) to compare the prevalence […]
The theory behind the diet, which is the brainchild of Roy Taylor, professor of medicine and metabolism at Newcastle University, is based on the fact that type 2 diabetes is often caused by fat clogging up the liver and pancreas, which are crucial in producing insulin and controlling blood sugar.
If you suffer from Type 2 diabetes or hypertension, you should be evaluated for obstructive sleep apnea (OSA) by a physician who is board-certified in sleep medicine. This is a recommendation recently issued for the first time by the American Academy of Sleep Medicine (AASM)
Kamlesh Khunti, MD, of the University of Leicester in England, and colleagues reported that, in a retrospective study, patients who had an HbA1c of 7% at baseline had a median time to intensification with one additional oral anti-diabetic drug of 2.9 years.
A cross-sectional study examined the relationship between obstructive sleep apnea (OAS) and type 2 diabetes (T2DM), and risk factors (obesity, hypertension, and impaired glucose tolerance).
This retrospective cohort study determined the effect of colesevelam HCL initiation and A1C level in patients with type 2 diabetes regardless of other anti-diabetic medication use.
Patients with diabetes who take certain types of medications to lower their blood sugar sometimes experience severe low blood-sugar levels, whether or not their diabetes is poorly or well controlled, according to a new study by Kaiser Permanente and Yale University School of Medicine.
A research team led by Nicholas Stylopoulos, HMS assistant professor of pediatrics at Boston Children’s Hospital, has identified the small intestine—widely believed to be a passive organ—as the major contributor to the body’s metabolism, based on a study in rats. The report appears in the July 26, 2013, issue of Science.
A new pooled analysis shows DPP-4 inhibitors have a greater safety and tolerability profile when compared to other antihyperglycemic agents.
The reason some patients are cured of type-2 diabetes after a gastric bypass may have been explained by US researchers.
According to Dr. Roy Taylor of the United Kingdom’s University of Newcastle, we need to change our understanding of what causes Type 2 diabetes. Then we can treat it and reverse it. What is this new understanding?
Previous studies examining the risk of disability associated with diabetes have produced varying results, ranging from no association, to a doubling of risk. The new study is the first meta-analysis to pool estimates taken from earlier studies, providing a more reliable estimate of the likely risk of disability associated with diabetes.
The resistance to insulin seen in type 2 diabetics is caused partly by the lack of a protein that has not previously been associated with diabetes. This breakthrough could potentially help to prevent diabetes.